These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 16980204)

  • 41. Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheochromocytoma and Paraganglioma.
    Patel D; Phay JE; Yen TWF; Dickson PV; Wang TS; Garcia R; Yang AD; Solórzano CC; Kim LT
    Ann Surg Oncol; 2020 May; 27(5):1329-1337. PubMed ID: 32112212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnosis and Management of Hereditary Phaeochromocytoma and Paraganglioma.
    Lalloo F
    Recent Results Cancer Res; 2016; 205():105-24. PubMed ID: 27075351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New advances in the genetics of pheochromocytoma and paraganglioma syndromes.
    Gimenez-Roqueplo AP
    Ann N Y Acad Sci; 2006 Aug; 1073():112-21. PubMed ID: 17102078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Paraganglioma genes.
    Chew SL
    Clin Endocrinol (Oxf); 2001 May; 54(5):573-4. PubMed ID: 11380486
    [No Abstract]   [Full Text] [Related]  

  • 45. [Pediatric pheochromocytoma and paraganglioma: an update].
    Garnier S; Réguerre Y; Orbach D; Brugières L; Kalfa N
    Bull Cancer; 2014 Oct; 101(10):966-75. PubMed ID: 25373696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel mutation in the TMEM127 gene associated with phaeochromocytoma.
    Elston MS; Meyer-Rochow GY; Prosser D; Love DR; Conaglen JV
    Intern Med J; 2013 Apr; 43(4):449-51. PubMed ID: 23551308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hereditary pheochromocytoma and paraganglioma].
    Musil Z; Vícha A; Zelinka T; Turková H; Labudová T; Kohoutová M; Pacák K
    Klin Onkol; 2012; 25 Suppl():S21-6. PubMed ID: 22920202
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic aspects of pheochromocytoma.
    Koch CA; Vortmeyer AO; Huang SC; Alesci S; Zhuang Z; Pacak K
    Endocr Regul; 2001 Mar; 35(1):43-52. PubMed ID: 11308996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. When should genetic testing be obtained in a patient with phaeochromocytoma or paraganglioma?
    Erlic Z; Neumann HP
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):354-7. PubMed ID: 19067729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathology and genetics of phaeochromocytoma and paraganglioma.
    Turchini J; Cheung VKY; Tischler AS; De Krijger RR; Gill AJ
    Histopathology; 2018 Jan; 72(1):97-105. PubMed ID: 29239044
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The pressure rises: update on the genetics of phaeochromocytoma.
    Maher ER; Eng C
    Hum Mol Genet; 2002 Oct; 11(20):2347-54. PubMed ID: 12351569
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Perioperative outcomes of syndromic paraganglioma and pheochromocytoma resection in patients with von Hippel-Lindau disease, multiple endocrine neoplasia type 2, or neurofibromatosis type 1.
    Butz JJ; Yan Q; McKenzie TJ; Weingarten TN; Cavalcante AN; Bancos I; Young WF; Schroeder DR; Martin DP; Sprung J
    Surgery; 2017 Dec; 162(6):1259-1269. PubMed ID: 28919049
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Genetic and molecular bases of paragangliomas].
    Núñez Lozano M; González Sarmiento R
    Acta Otorrinolaringol Esp; 2009 Feb; 60 Suppl 1():24-8. PubMed ID: 19245772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The approach to the patient with paraganglioma.
    Neumann HP; Eng C
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2677-83. PubMed ID: 19657044
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel SDHD germ-line mutations in pheochromocytoma patients.
    Neumayer C; Moritz A; Asari R; Weinhäusel A; Hölzenbein T; Kretschmer G; Niederle B; Haas OA
    Eur J Clin Invest; 2007 Jul; 37(7):544-51. PubMed ID: 17576205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Diagnostic and therapeutic procedures in pheochromocytoma: current trends].
    Widimský J; Zelinka T; Petrák O; Strauch B; Safarík L; Kasalický M; Vranková A; Holaj R
    Vnitr Lek; 2007 Apr; 53(4):428-33. PubMed ID: 17578179
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent insights into the molecular pathogenesis of pheochromocytoma and paraganglioma.
    Nakamura E; Kaelin WG
    Endocr Pathol; 2006; 17(2):97-106. PubMed ID: 17159241
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Next-generation panel sequencing identifies
    Gieldon L; Masjkur JR; Richter S; Därr R; Lahera M; Aust D; Zeugner S; Rump A; Hackmann K; Tzschach A; Januszewicz A; Prejbisz A; Eisenhofer G; Schrock E; Robledo M; Klink B
    Eur J Endocrinol; 2018 Feb; 178(2):K1-K9. PubMed ID: 29158289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pheochromocytoma and sympathetic paraganglioma. 2. Combination with typical associated diseases. Familial occurrence].
    Zollinger R; Hedinger C
    Schweiz Med Wochenschr; 1983 Aug; 113(31-32):1086-92. PubMed ID: 6137873
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Genetics of pheochromocytoma and the relevance in surgery].
    von Dobschütz E; Neumann HPH
    Chirurg; 2019 Jan; 90(1):15-22. PubMed ID: 30306232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.